Literature DB >> 22607834

The economic costs of pain in the United States.

Darrell J Gaskin1, Patrick Richard.   

Abstract

UNLABELLED: In 2008, according to the Medical Expenditure Panel Survey (MEPS), about 100 million adults in the United States were affected by chronic pain, including joint pain or arthritis. Pain is costly to the nation because it requires medical treatment and complicates treatment for other ailments. Also, pain lowers worker productivity. Using the 2008 MEPS, we estimated 1) the portion of total U.S. health care costs attributable to pain; and 2) the annual costs of pain associated with lower worker productivity. We found that the total costs ranged from $560 to $635 billion in 2010 dollars. The additional health care costs due to pain ranged from $261 to $300 billion. This represents an increase in annual per person health care costs ranging from $261 to $300 compared to a base of about $4,250 for persons without pain. The value of lost productivity due to pain ranged from $299 to $335 billion. We found that the annual cost of pain was greater than the annual costs of heart disease ($309 billion), cancer ($243 billion), and diabetes ($188 billion). Our estimates are conservative because they do not include costs associated with pain for nursing home residents, children, military personnel, and persons who are incarcerated. PERSPECTIVE: This study estimates that the national cost of pain ranges from $560 to $635 billion, larger than the cost of the nation's priority health conditions. Because of its economic toll on society, the nation should invest in research, education, and training to advocate the successful treatment, management, and prevention of pain.
Copyright © 2012 American Pain Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22607834     DOI: 10.1016/j.jpain.2012.03.009

Source DB:  PubMed          Journal:  J Pain        ISSN: 1526-5900            Impact factor:   5.820


  570 in total

1.  Pain Status as a Predictor of Smoking Cessation Initiation, Lapse, and Relapse.

Authors:  Joseph W Ditre; Bryan W Heckman; Lisa R LaRowe; Jessica M Powers
Journal:  Nicotine Tob Res       Date:  2021-01-07       Impact factor: 4.244

2.  Insurance status and health-related quality-of-life disparities after trauma: results from a nationally representative survey in the US.

Authors:  Suliman Alghnam; Eric B Schneider; Renan C Castillo
Journal:  Qual Life Res       Date:  2015-09-04       Impact factor: 4.147

Review 3.  The Assessment and Non-Pharmacologic Treatment of Procedural Pain From Infancy to School Age Through a Developmental Lens: A Synthesis of Evidence With Recommendations.

Authors:  Susan E Thrane; Shannon Wanless; Susan M Cohen; Cynthia A Danford
Journal:  J Pediatr Nurs       Date:  2015-09-28       Impact factor: 2.145

Review 4.  Intrathecal Analgesia for Chronic Refractory Pain: Current and Future Prospects.

Authors:  Catherine Smyth; Nadera Ahmadzai; Jason Wentzell; Ashley Pardoe; Andrew Tse; Tiffany Nguyen; Yvette Goddard; Shona Nair; Patricia A Poulin; Becky Skidmore; Mohammed T Ansari
Journal:  Drugs       Date:  2015-11       Impact factor: 9.546

5.  Chronic refractory myofascial pain and denervation supersensitivity as global public health disease.

Authors:  J Chu; F Bruyninckx; D V Neuhauser
Journal:  BMJ Case Rep       Date:  2016-01-13

6.  A Randomized, Controlled Trial of Wholistic Hybrid Derived From Eye Movement Desensitization and Reprocessing and Emotional Freedom Technique (WHEE) for Self-Treatment of Pain, Depression, and Anxiety in Chronic Pain Patients.

Authors:  Daniel Benor; John Rossiter-Thornton; Loren Toussaint
Journal:  J Evid Based Complementary Altern Med       Date:  2016-07-20

7.  Effects of nicotine deprivation on current pain intensity among daily cigarette smokers.

Authors:  Lisa R LaRowe; Jesse D Kosiba; Emily L Zale; Joseph W Ditre
Journal:  Exp Clin Psychopharmacol       Date:  2018-07-23       Impact factor: 3.157

Review 8.  Investigational peptide and peptidomimetic μ and δ opioid receptor agonists in the relief of pain.

Authors:  Aswini Kumar Giri; Victor J Hruby
Journal:  Expert Opin Investig Drugs       Date:  2013-12-13       Impact factor: 6.206

9.  Naldemedine (Symproic) for the Treatment Of Opioid-Induced Constipation.

Authors:  Kenneth Hu; Mary Barna Bridgeman
Journal:  P T       Date:  2018-10

10.  Opioid Prescriptions for Acute and Chronic Pain Management Among Medicaid Beneficiaries.

Authors:  Chandrashekar Janakiram; Paul Fontelo; Vojtech Huser; Natalia I Chalmers; Gabriela Lopez Mitnik; Avery R Brow; Timothy J Iafolla; Bruce A Dye
Journal:  Am J Prev Med       Date:  2019-08-01       Impact factor: 5.043

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.